secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001104659-25-078752
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet Biosciences enters $75M ATM equity facility with Leerink Partners, terminates prior Cantor facility
--------------------------------------------------------------------------------

- Up to $75M in common stock may be sold from time to time via at-the-market offerings through Leerink Partners.
- Agent commission of up to 3.0% on gross proceeds from sales under the agreement.
- Prior Cantor Fitzgerald ATM agreement terminated effective Aug 14, 2025; no shares were sold under that facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465925078752/0001104659-25-078752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465925078752/tm2523529d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-078752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer